← ANALYST RATINGS · TIPRANKS
Electra Therapeutics Inc. (ETRA): analyst forecast and price target
Analyst consensus
Strong Buy4 Buy0 Hold0 Sell
Ratings of 4 analysts in the last 3 months12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $25.77, the highest $36.00, the lowest $9.32. The average is +194.6% from the last price of $8.75.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Akash Tewari★★★★★★★★★★#649 · hits 57% · avg +13.5% | Jefferies | $32.00 | Buy | +265.7% | Initiated | 13.10.26on TipRanks Oct 14 02:00 | −7.6%next day +4.9% | ↗ |
| Cory Kasimov★★★★★★★★★★#276 · hits 59% · avg +18.9% | Evercore ISI | $36.00 | Buy | +311.4% | Initiated | 13.10.26on TipRanks Oct 14 02:00 | −7.6%next day +4.9% | ↗ |
| Eric Schmidt FCA★★★★★★★★★★#358 · hits 51% · avg +84.1% | Cantor Fitzgerald | — | Buy | — | Initiated | 13.10.26on TipRanks 06:35 | −7.6%next day +4.9% | ↗ |
| Tyler Van Buren★★★★★★★★★★#42 · hits 64% · avg +38.8% | TD Cowen | $9.32 | Buy | +6.5% | Initiated | 13.10.26on TipRanks 05:45 | −7.6%next day +4.9% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 13.10.26: target $9.32 at a price of $9.32 (0.0%); now: $25.77 at $8.75 (+194.6%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Best top-analyst consensus in the sector · General
About Electra Therapeutics Inc.
- CEO: Quehuong Dong
- Employees: 46
- 230 E Grand Avenue, South San Francisco, CA, 94080, US
- www.electra-therapeutics.com
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Data from the stock’s TipRanks forecast page, read 180 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗